On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.